NEW YORK (GenomeWeb News) ¯ Oxford Gene Technology yesterday said it has granted Phalanx Biotech Group a license to its Southern array patents.
 
The deal enables Taiwan-based Phalanx to sell arrays, including its whole-genome OneArray platform, for gene expression-profile studies in the US.
 
The license is valid for the patents’ lifetime.
 
Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.